Chemomab Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Chemomab Therapeutics stock have an average target of 9.00, with a low estimate of 7.00 and a high estimate of 11. The average target predicts an increase of 765.38% from the current stock price of 1.04.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$9.00	$11	$11
Change	+573.08%	+765.38%	+957.69%	+957.69%

* Price targets were last updated on Feb 20, 2025.

Analyst Ratings

The average analyst rating for Chemomab Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Maintains $4 → $7	Strong Buy	Maintains	$4 → $7	+573.08%	Feb 20, 2025
Jeff Jones Oppenheimer	Oppenheimer	Buy Reiterates $13 → $11	Buy	Reiterates	$13 → $11	+957.69%	Nov 15, 2024
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Initiates $4	Strong Buy	Initiates	$4	+284.62%	May 13, 2024
Jeff Jones Oppenheimer	Oppenheimer	Hold → Buy Upgrades $6	Hold → Buy	Upgrades	$6	+476.92%	May 6, 2024
Jeff Jones Oppenheimer	Oppenheimer	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Mar 8, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 33.88M

Revenue Next Year

n/a

EPS This Year

-0.40

from -0.86

EPS Next Year

-0.39

from -0.40

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	-	33.88M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-0.87	-1.20	-2.43	-2.06	-0.86	-0.40	-0.39	-0.40
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.04	-0.05	-0.05
Avg	-0.40	-0.39	-0.40
Low	-0.73	-0.70	-0.73

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.